For Physicians Managing Voiding Dysfunction, Improving the Detection Rate of Early Prostate Cancer and Discrimination From Benign Prostatic Hyperplasia, in a Molecular Biomarker Aspects
Won Tae Kim, Seok Joong Yun, Wun-Jae Kim
Int Neurourol J. 2019;23(1):5-12. Published online 2019 Mar 31 DOI: https://doi.org/10.5213/inj.1836262.131
Citations to this article as recorded by 
Accuracy of novel urinary biomarker tests in the diagnosis of prostate cancer: A systematic review and network meta-analysis
Leibo Wang, Wei He, Guanyu Shi, Guoqiang Zhao, Zhuangding Cen, Feng Xu, Wu Tian, Xin Zhao, Chishou Mo
Frontiers in Oncology.2022;[Epub] CrossRef
Lower Urinary Tract Symptoms in Prostate Cancer Patients Treated With Radiation Therapy: Past and Present
Whi-An Kwon, Seo-Yeon Lee, Tae Yoong Jeong, Hong Sang Moon
International Neurourology Journal.2021; 25(2): 119. CrossRef
Plasmonic Metasurfaces for Medical Diagnosis Applications: A Review
Zhenbiao Wang, Junjie Chen, Sayed Ali Khan, Fajun Li, Jiaqing Shen, Qilin Duan, Xueying Liu, Jinfeng Zhu
Sensors.2021; 22(1): 133. CrossRef
Recent progress on developing of plasmon biosensing of tumor biomarkers: Efficient method towards early stage recognition of cancer
Zahra Fattahi, Ahmad Yari Khosroushahi, Mohammad Hasanzadeh
Biomedicine & Pharmacotherapy.2020; 132: 110850. CrossRef